Professor Neil Basu

Professor of Musculoskeletal Medicine & Vasculitis (Immunology & Infection)

telephone: 01413301718
email: Neil.Basu@glasgow.ac.uk

Research interests

My research programmes are inspired by my clinical practice where I am drawn to particular areas of considerable need:

Central Nervous System Determined Behaviours in Inflammatory Disease -

Despite the recent therapeutic revolution among inflammatory diseases such as rheumatoid arthritis, patients remain disabled by symptoms such as pain and fatigue. This multi-disciplinary translational portfolio aims to decipher these commanding symptoms by evaluating the roles of neurobiological and inflammatory factors.

Epidemiology of Systemic Vasculitis -

Inflammatory diseases such as systemic vasculitis are frequently overlooked due to their low prevalence. Patients feel marginalised and their true disease burden remains to be fully quantified. This programme of work seeks to apply descriptive, analytical and translational epidemiological methods to better quantify the burden and determinants of systemic vasculitis with view to informing and executing clinical trials.

Publications

List by: Type | Date

Jump to: 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 | 2008 | 2007 | 2005 | 2002

Number of items: 99.

2023

Michael, B. D. et al. (2023) Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nature Communications, 14, 8487. (doi: 10.1038/s41467-023-42320-4) (PMID:38135686) (PMCID:PMC10746705)

Brock, J., Basu, N. , Schlachetzki, J. C. M., Schett, G., McInnes, I. B. and Cavanagh, J. (2023) Immune mechanisms of depression in rheumatoid arthritis. Nature Reviews Rheumatology, 19(12), pp. 790-804. (doi: 10.1038/s41584-023-01037-w) (PMID:37923863)

Chong, H. Y. et al. (2023) Cost-effectiveness of cognitive behavioural and personalised exercise interventions for reducing fatigue in inflammatory rheumatic diseases. Rheumatology, 62(12), pp. 3819-3827. (doi: 10.1093/rheumatology/kead157) (PMID:37018151)

Dehsarvi, A. et al. (2023) Characterizing the neurobiological mechanisms of action of exercise and cognitive–behavioral interventions for rheumatoid arthritis fatigue: a magnetic resonance imaging brain study. Arthritis and Rheumatology, (doi: 10.1002/art.42755) (Early Online Publication)

Gisslander, K. et al. (2023) Data quality and patient characteristics in European ANCA associated vasculitis registries – data retrieval by federated querying. Annals of the Rheumatic Diseases, (doi: 10.1136/ard-2023-224571) (PMID:37907255) (Early Online Publication)

Barnes, E. et al. (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29(7), pp. 1760-1774. (doi: 10.1038/s41591-023-02414-4) (PMID:37414897) (PMCID:PMC10353927)

Sunzini, F., Schrepf, A., Clauw, D. J. and Basu, N. (2023) The biology of pain: through the rheumatology lens. Arthritis and Rheumatology, 75(5), pp. 650-660. (doi: 10.1002/art.42429) (PMID:36599071)

Winthrop, K. L. et al. (2023) Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the Rheumatic Diseases, 82(5), pp. 594-598. (doi: 10.1136/ard-2022-223528) (PMID:36702529)

Stefanov, K. , Al-Wasity, S., Parkinson, J. T. , Waiter, G. D., Cavanagh, J. and Basu, N. (2023) Brain mapping inflammatory arthritis related fatigue in the pursuit of novel therapeutics. Lancet Rheumatology, 5(2), e99-e109. (doi: 10.1016/S2665-9913(23)00007-3)

2022

Bachmair, E.-M. et al. (2022) Remotely delivered cognitive behavioural and personalised exercise interventions for fatigue severity and impact in inflammatory rheumatic diseases (LIFT): a multicentre, randomised, controlled, open-label, parallel-group trial. Lancet Rheumatology, 4(8), e534-e545. (doi: 10.1016/S2665-9913(22)00156-4)

Goñi, M., Basu, N. , Murray, A. D. and Waiter, G. D. (2022) Brain predictors of fatigue in Rheumatoid Arthritis: a machine learning study. PLoS ONE, 17(6), e0269952. (doi: 10.1371/journal.pone.0269952) (PMID:35759489) (PMCID:PMC9236264)

Scott, J. et al. (2022) The association between ambient UVB dose and ANCA-associated vasculitis relapse and onset. Arthritis Research and Therapy, 24(1), 147. (doi: 10.1186/s13075-022-02834-6) (PMID:35717248) (PMCID:PMC9206351)

Goebel, A. et al. (2022) Research recommendations following the discovery of pain sensitising IgG autoantibodies in fibromyalgia syndrome. Pain Medicine, 23(6), pp. 1084-1094. (doi: 10.1093/pm/pnab338) (PMID:34850195) (PMCID:PMC9157149)

Rutherford, M. A. and Basu, N. (2022) Reply to Riza and Hamit comment on ‘Factors influencing severe COVID‐19 in systemic vasculitis patients’. Arthritis and Rheumatology, 74(4), pp. 725-726. (doi: 10.1002/art.42024) (PMID:34783446) (PMCID:PMC8652784)

Montoye, A. H.K., Vondrasek, J. D., Neph, S. E., Basu, N. , Paul, L., Bachmair, E.-M., Stefanov, K. and Gray, S. R. (2022) Comparison of the activPAL CREA and VANE algorithms for characterization of posture and activity in free-living adults. Journal for the Measurement of Physical Behaviour, 5(1), pp. 49-57. (doi: 10.1123/jmpb.2021-0053)

Bennett, S. E., Almeida, C., Bachmair, E.-M., Gray, S. R. , Lovell, K., Paul, L., Wearden, A., Macfarlane, G. J., Basu, N. and Dures, E. (2022) Remotely delivered cognitive-behavioural and personalised exercise interventions to lessen the impact of fatigue: a qualitative evaluation. Rheumatology Advances in Practice, 6(2), rkac051. (doi: 10.1093/rap/rkac051) (PMID:35795008) (PMCID:PMC9252174)

Bennett, S. E., Almeida, C., Bachmair, E.-M., Gray, S. R. , Lovell, K., Paul, L., Wearden, A., Macfarlane, G. J., Basu, N. and Dures, E. (2022) Therapists’ experiences of remotely delivering cognitive-behavioural or graded-exercise interventions for fatigue: a qualitative evaluation. Rheumatology Advances in Practice, 6(3), rkac083. (doi: 10.1093/rap/rkac083) (PMID:36340509) (PMCID:PMC9629972)

2021

Fragoulis, G. E., Brock, J., Basu, N. , McInnes, I. B. and Siebert, S. (2021) The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions. Journal of Allergy and Clinical Immunology, 148(4), pp. 941-952. (doi: 10.1016/j.jaci.2021.08.010) (PMID:34450118)

Philobos, M., Perkins, A., Karabyas, M., Dospinescu, P., Fluck, N., Kidder, D., Chapman, F., Dhaun, N. and Basu, N. (2021) A real-world assessment of mycophenolate mofetil for remission-induction in eosinophilic granulomatosis with polyangiitis. Rheumatology International, 41(10), pp. 1811-1814. (doi: 10.1007/s00296-021-04961-w) (PMID:34350491)

Pugh, D., Grayson, P., Basu, N. and Dhaun, N. (2021) Aortitis: recent advances, current concepts and future possibilities. Heart, 107(20), pp. 1620-1629. (doi: 10.1136/heartjnl-2020-318085) (PMID:33593995)

Rutherford, M. A. et al. (2021) Risk factors for severe outcomes in patients with systemic vasculitis & COVID-19: a bi-national registry-based cohort study. Arthritis and Rheumatology, 73(9), pp. 1713-1719. (doi: 10.1002/art.41728) (PMID:33750043) (PMCID:PMC8251299)

Macfarlane, G. J. et al. (2021) Maintaining musculoskeletal health using a behavioural therapy approach: a population-based randomised controlled trial (the MAmMOTH study). Annals of the Rheumatic Diseases, 80(7), pp. 903-911. (doi: 10.1136/annrheumdis-2020-219091) (PMID:33526434)

Derakhshan, M. H., Morton, F. , Fragoulis, G. E., Paterson, C., Dale, J., Basu, N. , Mcinnes, I., Porter, D. and Siebert, S. (2021) Opioids and analgesic use in early rheumatoid arthritis: a longitudinal analysis of linked real-world prescription data. Annals of the Rheumatic Diseases 80(S1): 1159. EULAR 2021 Virtual Congress., 2-5 June 2021. (doi: 10.1136/annrheumdis-2021-eular.2672)

Kelly, C. A. et al. (2021) Rheumatoid arthritis related interstitial lung disease – improving outcomes over 25 years: a large multicentre UK study. Rheumatology, 60(4), pp. 1882-1890. (doi: 10.1093/rheumatology/keaa577) (PMID:33150434)

Sarica, S. H. et al. (2021) Multimorbidity in anti-neutrophil cytoplasmic antibody-associated vasculitis: results from a longitudinal, multi-centre data-linkage study. Arthritis and Rheumatology, 73(4), pp. 651-659. (doi: 10.1002/art.41557) (PMID:33058567)

King, C., Druce, K. L., Nightingale, P., Kay, E., Basu, N. , Salama, A. D. and Harper, L. (2021) Predicting relapse in ANCA-associated vasculitis: a systematic review and meta-analysis. Rheumatology Advances in Practice, 5(3), rkab018. (doi: 10.1093/rap/rkab018) (PMID:34476335) (PMCID:PMC8407598)

Pugh, D. et al. (2021) Large-vessel vasculitis. Nature Reviews Disease Primers, 7, 93. (doi: 10.1038/s41572-021-00327-5) (PMID:34992251)

2020

Karabayas, M., Dospinescu, P., Fluck, N., Kidder, D., Fordyce, G., Hollick, R.J., De Bari, C. and Basu, N. (2020) Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis. Rheumatology Advances in Practice, 4(2), rkaa069. (doi: 10.1093/rap/rkaa069) (PMID:33381680) (PMCID:PMC7756006)

Shim, J., Dean, L. E., Karabayas, M., Jones, G. T., Macfarlane, G. J. and Basu, N. (2020) Quantifying and predicting the effect of anti-TNF therapy on axSpA-related fatigue: results from the BSRBR-AS registry and meta-analysis. Rheumatology, 59(11), pp. 3408-3414. (doi: 10.1093/rheumatology/keaa132) (PMID:32337555) (PMCID:PMC7590410)

Sarica, S. H. et al. (2020) Characterizing infection in anti-neutrophil cytoplasmic antibody–associated vasculitis: results from a longitudinal, matched-cohort data linkage study. Rheumatology, 59(10), pp. 3014-3022. (doi: 10.1093/rheumatology/keaa070) (PMID:32159801) (PMCID:PMC7516107)

Dures, E. and Basu, N. (2020) Fatigue. In: Scott, D. L., Galloway, J., Cope, A., Pratt, A. and Strand, V. (eds.) Oxford Textbook of Rheumatoid Arthritis. Oxford University Press: Oxford. ISBN 9780198831433

Porter, D., Basu, N. and Siebert, S. (2020) Classification criteria: time for a rethink? Annals of the Rheumatic Diseases, 79(10), pp. 1264-1266. (doi: 10.1136/annrheumdis-2020-217769) (PMID:32699035)

Stefanov, K. , McLean, J., McColl, A., Basu, N. , Cavanagh, J. and Krishnadas, R. (2020) Mild inflammation in healthy males induces fatigue mediated by changes in effective connectivity within the insula. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 5(9), pp. 865-874. (doi: 10.1016/j.bpsc.2020.04.005) (PMID:32532687)

Kitching, A. R., Anders, H.-J. and Basu, N. (2020) ANCA-associated vasculitis. Nature Reviews Disease Primers, 6, 71. (doi: 10.1038/s41572-020-0204-y) (PMID:32855422)

Karabayas, M., Dospinescu, P., Locherty, M., Moulindu, P., Sobti, M., Hollick, R., De Bari, C., Robinson, S., Olson, J. and Basu, N. (2020) Stratified glucocorticoid monotherapy is safe and effective for most cases of giant cell arteritis. Rheumatology Advances in Practice, 4(2), rkaa024. (doi: 10.1093/rap/rkaa024) (PMID:32914048) (PMCID:PMC7474854)

Aitken, M. and Basu, N. (2020) Improving quality of life in vasculitis patients. Rheumatology, 59(Supple), iii132-iii135. (doi: 10.1093/rheumatology/kez546) (PMID:32348508)

O'Malley, L., Druce, K., Chanouzas, D., Morgan, M., Jones, R., Jayne, D., Basu, N. and Harper, L. (2020) The longitudinal course of fatigue in antineutrophil cytoplasmic antibody–associated vasculitis. Journal of Rheumatology, 47(4), pp. 572-579. (doi: 10.3899/jrheum.190113) (PMID:31263068)

Tieu, J. et al. (2020) Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines. Rheumatology, 59(4), e24-e32. (doi: 10.1093/rheumatology/kez640) (PMID:32096545)

Schrepf, A., Moser, S., Harte, S. E., Basu, N. , Kaplan, C., Kolarik, E., Tsodikov, A., Brummett, C. M. and Clauw, D. J. (2020) Top down or bottom up? An observational investigation of improvement in fibromyalgia symptoms following hip and knee replacement. Rheumatology, 59(3), pp. 594-602. (doi: 10.1093/rheumatology/kez303) (PMID:31411333)

Kaplan, C. M., Schrepf, A., Ichesco, E., Larkin, T., Harte, S. E., Harris, R. E., Murray, A. D., Waiter, G. D., Clauw, D. J. and Basu, N. (2020) Association of inflammation with pronociceptive brain connections in rheumatoid arthritis patients with concomitant fibromyalgia. Arthritis and Rheumatology, 72(1), pp. 41-46. (doi: 10.1002/art.41069) (PMID:31379121)

Walls, C. A., Basu, N. , Hutcheon, G., Erwig, L. P., Little, M. A. and Kidder, D. (2020) A novel 4-dimensional live-cell imaging system to study leukocyte-endothelial dynamics in ANCA-associated vasculitis. Autoimmunity, 53(3), pp. 148-155. (doi: 10.1080/08916934.2019.1704274) (PMID:31865776)

2019

Kaplan, C., Minc, A., Basu, N. and Schrepf, A. (2019) Inflammation and the central nervous system in inflammatory rheumatic disease. Current Rheumatology Reports, 21(12), 67. (doi: 10.1007/s11926-019-0870-5) (PMID:31807958)

Cheung, S. M. et al. (2019) Metabolic and structural skeletal muscle health in systemic lupus erythematosus related fatigue: a multi-modal magnetic resonance imaging study. Arthritis Care and Research, 71(12), pp. 1640-1646. (doi: 10.1002/acr.23833) (PMID:30629805)

Druce, K. L. and Basu, N. (2019) Predictors of fatigue in rheumatoid arthritis. Rheumatology, 58(S5), v29-v34. (doi: 10.1093/rheumatology/kez346) (PMID:31435677) (PMCID:PMC6827266)

Basu, N. , Kaplan, C. M., Ichesco, E., Larkin, T., Schrepf, A., Murray, A. D., Clauw, D. J., Waiter, G. D. and Harris, R. E. (2019) Functional and structural magnetic resonance imaging correlates of fatigue in patients with rheumatoid arthritis. Rheumatology, 58(10), pp. 1822-1830. (doi: 10.1093/rheumatology/kez132) (PMID:31330004)

Farrah, T. E., Basu, N. , Dweck, M., Calcagno, C., Fayad, Z. A. and Dhaun, N. (2019) Advances in therapies and imaging for systemic vasculitis. Arteriosclerosis, Thrombosis, and Vascular Biology, 39, pp. 1520-1541. (doi: 10.1161/atvbaha.118.310957) (PMID:31189432)

Chanouzas, D. et al. (2019) Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study. BMC Nephrology, 20, 58. (doi: 10.1186/s12882-019-1226-0) (PMID:30777023) (PMCID:PMC6378728)

Beasley, M., Freidin, M. B., Basu, N. , Williams, F. M.K. and Macfarlane, G. J. (2019) What is the effect of alcohol consumption on the risk of chronic widespread pain? A Mendelian randomisation study using UK Biobank. Pain, 160(2), pp. 501-507. (doi: 10.1097/j.pain.0000000000001426) (PMID:30371560)

Kratz, A. L., Murphy, S. L., Braley, T. J., Basu, N. , Kulkarni, S., Russell, J. and Carlozzi, N. E. (2019) Development of a person-centered conceptual model of perceived fatigability. Quality of Life Research, 28, pp. 1337-1347. (doi: 10.1007/s11136-018-2093-z) (PMID:30604341) (PMCID:PMC7395299)

Martin, K. R. et al. (2019) Protocol for a multicentre randomised controlled parallel-group trial to compare the effectiveness of remotely delivered cognitive-behavioural and graded exercise interventions with usual care alone to lessen the impact of fatigue in inflammatory rheumatic diseases (LIFT). BMJ Open, 9(1), e026793. (doi: 10.1136/bmjopen-2018-026793) (PMID:30705244) (PMCID:PMC6359876)

Lyons, P. A. et al. (2019) Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status. Nature Communications, 10, 5120. (doi: 10.1038/s41467-019-12515-9) (PMID:31719529) (PMCID:PMC6851141)

2018

Schrepf, A. et al. (2018) Sensory sensitivity and symptom severity represent unique dimensions of chronic pain: a MAPP Research Network study. Pain, 159(10), pp. 2002-2011. (doi: 10.1097/j.pain.0000000000001299) (PMID:29863527)

Basu, N. , Kaplan, C. M., Ichesco, E., Larkin, T., Harris, R. E., Murray, A., Waiter, G. and Clauw, D. J. (2018) Neurobiologic features of fibromyalgia are also present among rheumatoid arthritis patients. Arthritis and Rheumatology, 70(7), pp. 1000-1007. (doi: 10.1002/art.40451) (PMID:29439291)

Matraiah, E. H., Olisaka, N., Philipos, M., Walbaum, D., Dospinescu, P., Fluck, N., Basu, N. and Kidder, D. (2018) Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis. Clinical Rheumatology, 37(7), pp. 1991-1996. (doi: 10.1007/s10067-018-4155-6) (PMID:29808456)

Goñi, M., Basu, N. , Murray, A. D. and Waiter, G. D. (2018) Neural indicators of fatigue in chronic diseases: a systematic review of MRI studies. Diagnostics, 8(3), 42. (doi: 10.3390/diagnostics8030042) (PMID:29933643) (PMCID:PMC6163988)

Schrepf, A., Kaplan, C. M., Ichesco, E., Larkin, T., Harte, S. E., Harris, R. E., Murray, A. D., Waiter, G. D., Clauw, D. J. and Basu, N. (2018) A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis. Nature Communications, 9, 2243. (doi: 10.1038/s41467-018-04648-0) (PMID:29884867) (PMCID:PMC5993749)

Druce, K. L., Aikman, L., Dilleen, M., Burden, A., Szczypa, P. and Basu, N. (2018) Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients. Arthritis Research and Therapy, 20(1), 96. (doi: 10.1186/s13075-018-1598-8) (PMID:29843776) (PMCID:PMC5972438)

Basu, N. , Karabayas, M. and Pusey, C. (2018) Prognosis and future developments in vasculitis. Best Practice and Research: Clinical Rheumatology, 32(1), pp. 148-165. (doi: 10.1016/j.berh.2018.08.011) (PMID:30526894)

Kidder, D., Dospinescu, P., Karabayas, M. and Basu, N. (2018) Systemic vasculitides: an overview. Medicine, 46(2), pp. 93-97. (doi: 10.1016/j.mpmed.2017.11.001)

Maldini, C., Druce, K., Basu, N. , LaValley, M. P. and Mahr, A. (2018) Exploring the variability in Behçet’s disease prevalence: a meta-analytical approach. Rheumatology, 57(1), pp. 185-195. (doi: 10.1093/rheumatology/kew486) (PMID:28339670)

2017

Basu, N. , Jones, G. T., Macfarlane, G. J. and Druce, K. L. (2017) Identification and validation of clinically relevant clusters of severe fatigue in rheumatoid arthritis. Psychosomatic Medicine, 79(9), pp. 1051-1058. (doi: 10.1097/PSY.0000000000000498) (PMID:28570437)

Harris, R. E., Ichesco, E., Cummiford, C., Hampson, J. P., Chenevert, T. L., Basu, N. and Zick, S. M. (2017) Brain connectivity patterns dissociate action of specific acupressure treatments in fatigued breast cancer survivors. Frontiers in Neurology, 8, 298. (doi: 10.3389/fneur.2017.00298) (PMID:28690587) (PMCID:PMC5481304)

2016

Whibley, D., Dean, L. E. and Basu, N. (2016) Management of widespread pain and fibromyalgia. Current Treatment Options in Rheumatology, 2(4), pp. 312-320. (doi: 10.1007/s40674-016-0056-5) (PMID:28936388) (PMCID:PMC5566487)

Dale, J. et al. (2016) The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank. BMC Musculoskeletal Disorders, 17, 461. (doi: 10.1186/s12891-016-1318-y) (PMID:27829394) (PMCID:PMC5103386)

Druce, K. L., Bhattacharya, Y., Jones, G. T., Macfarlane, G. J. and Basu, N. (2016) Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology, 55(10), pp. 1786-1790. (doi: 10.1093/rheumatology/kew241) (PMID:27330158)

McClean, A., Morgan, M. D., Basu, N. , Bosch, J. A., Nightingale, P., Jones, D. and Harper, L. (2016) Physical fatigue, fitness, and muscle function in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care and Research, 68(9), pp. 1332-1339. (doi: 10.1002/acr.22827) (PMID:26713864)

Basu, N. , Yang, X., Luben, R. N., Whibley, D., Macfarlane, G. J., Wareham, N. J., Khaw, K.-T. and Myint, P. K. (2016) Fatigue is associated with excess mortality in the general population: results from the EPIC-Norfolk study. BMC Medicine, 14, 122. (doi: 10.1186/s12916-016-0662-y) (PMID:27543008) (PMCID:PMC4992307)

Dahal, L. N., Basu, N. , Youssef, H., Khanolkar, R. C., Barker, R. N., Erwig, L. P. and Ward, F. J. (2016) Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. Arthritis Research and Therapy, 18(1), 180. (doi: 10.1186/s13075-016-1075-1)

Druce, K. L., Jones, G. T., Macfarlane, G. J. and Basu, N. (2016) Examining changes in central and peripheral pain as mediates of fatigue improvement: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Care and Research, 68(7), pp. 922-926. (doi: 10.1002/acr.22803) (PMID:26605992)

Kronisch, C. et al. (2016) Brief report: predicting functional disability: one-year results from the Scottish Early Rheumatoid Arthritis inception cohort. Arthritis and Rheumatology, 68(7), pp. 1596-1602. (doi: 10.1002/art.39627) (PMID:26866516)

Macfarlane, G. J. et al. (2016) The Maintaining Musculoskeletal Health (MAmMOTH) Study: Protocol for a randomised trial of cognitive behavioural therapy versus usual care for the prevention of chronic widespread pain. BMC Musculoskeletal Disorders, 17(1), 179. (doi: 10.1186/s12891-016-1037-4) (PMID:27113442) (PMCID:PMC4845348)

2015

Druce, K. L., Jones, G. T., Macfarlane, G. J., Verstappen, S. M.M. and Basu, N. (2015) The longitudinal course of fatigue in rheumatoid arthritis: results from the Norfolk Arthritis Register. Journal of Rheumatology, 42(11), pp. 2059-2065. (doi: 10.3899/jrheum.141498) (PMID:26472420)

Druce, K. L., Jones, G. T., Macfarlane, G. J. and Basu, N. (2015) Determining pathways to improvements in fatigue in rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register for rheumatoid arthritis. Arthritis and Rheumatology, 67(9), pp. 2303-2310. (doi: 10.1002/art.39238) (PMID:26108189)

Druce, K. L., Jones, G. T., Macfarlane, G. J. and Basu, N. (2015) Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology, 54(6), pp. 964-971. (doi: 10.1093/rheumatology/keu390) (PMID:25313148)

Sarica, S. and Basu, N. (2015) Patient priorities in vasculitis. Nephron, 129(2), pp. 6-8. (doi: 10.1159/000381120)

Watts, R. A., Mahr, A., Mohammad, A. J., Gatenby, P., Basu, N. and Flores-Suárez, L. F. (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrology Dialysis Transplantation, 30(S1), i14-i22. (doi: 10.1093/ndt/gfv022) (PMID:5805746)

Basu, N. , Hollick, R. and Mahr, A. (2015) Classification of vasculitis. In: EULAR Textbook on Rheumatic Diseases [2nd ed.]. EULAR, pp. 695-716.

2014

Basu, N. , Murray, A.D., Jones, G.T., Reid, D.M., Macfarlane, G.J. and Waiter, G.D. (2014) Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. Rheumatology, 53(11), pp. 2080-2087. (doi: 10.1093/rheumatology/keu243) (PMID:24929635)

Basu, N. et al. (2014) Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology, 53(5), pp. 953-956. (doi: 10.1093/rheumatology/ket483) (PMID:24489015)

Peschel, A., Basu, N. , Benharkou, A., Brandes, R., Brown, M., Dieckmann, R., Rees, A. J. and Kain, R. (2014) Autoantibodies to hLAMP-2 in ANCA-Negative pauci-immune focal necrotizing GN. Journal of the American Society of Nephrology, 25(3), pp. 455-463. (doi: 10.1681/ASN.2013030320) (PMID:24203998) (PMCID:PMC3935581)

Basu, N. et al. (2014) The characterisation and determinants of quality of life in ANCA associated vasculitis. Annals of the Rheumatic Diseases, 73(1), pp. 207-211. (doi: 10.1136/annrheumdis-2012-202750) (PMID:23355077)

Druce, K. and Basu, N. (2014) Fatigue in rheumatology: what can we target for treatment? International Journal of Clinical Rheumatology, 9(6), pp. 547-549.

2013

Basu, N. et al. (2013) Explaining fatigue in ANCA-associated vasculitis. Rheumatology, 52(9), pp. 1680-1685. (doi: 10.1093/rheumatology/ket191) (PMID:23740186)

Basu, N. , Murray, A. D., Jones, G. T., Reid, D., Macfarlane, G. J. and Waiter, G. D. (2013) Fatigue-related brain white matter changes in granulomatosis with polyangiitis. Rheumatology, 52(8), pp. 1429-1434. (doi: 10.1093/rheumatology/ket135) (PMID:23584367)

Macfarlane, G. J., Jones, G. T., Swafe, L., Reid, D. M. and Basu, N. (2013) Alternative population sampling frames produced important differences in estimates of association: a case–control study of vasculitis. Journal of Clinical Epidemiology, 66(6), pp. 675-680. (doi: 10.1016/j.jclinepi.2012.09.009) (PMID:23313107)

Dospinescu, P., Jones, G. T. and Basu, N. (2013) Environmental risk factors in systemic sclerosis. Current Opinion in Rheumatology, 25(2), pp. 179-183. (doi: 10.1097/BOR.0b013e32835cfc2d) (PMID:23287382)

Jennette, J.C. et al. (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis and Rheumatism, 65(1), pp. 1-11. (doi: 10.1002/art.37715) (PMID:23045170)

2011

Basu, N. and Erwig, L.-P. (2011) Pathophysiological importance of antineutrophil antibodies in vasculitis. Current Opinion in Hematology, 18(1), pp. 25-29. (doi: 10.1097/MOH.0b013e328340dc2a) (PMID:20975556) (PMCID:PMC3242048)

Basu, N. and Kumar, V. (2011) Musculoskeletal disorders. In: Currie, G. and Douglas, G. (eds.) The Flesh and Bones of Medicine. Elsevier, pp. 227-252.

Suppiah, R., Robson, J., Basu, N. and Luqmani, R. (2011) The need for diagnostic criteria in systemic vasculitis. Current Immunology Reviews, 7(4), pp. 394-401. (doi: 10.2174/157339511797535135)

2010

Basu, N. , Jones, G. T., Fluck, N., MacDonald, A. G., Pang, D., Dospinescu, P., Reid, D. M. and Macfarlane, G. J. (2010) Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology, 49(7), pp. 1383-1390. (doi: 10.1093/rheumatology/keq098) (PMID:20400759) (PMCID:PMC3091420)

Basu, N. et al. (2010) EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Annals of the Rheumatic Diseases, 69(10), pp. 1744-1750. (doi: 10.1136/ard.2009.119032) (PMID:20448283)

2009

Basu, N. and Steven, M. (2009) A comparison of rural and urban rheumatoid arthritis populations. Scottish Medical Journal, 54(1), pp. 7-9. (doi: 10.1258/rsmsmj.54.1.7) (PMID:19291927)

Suppiah, R., Basu, N. , Watts, R. and Luqmani, R. (2009) Advances in the classification of primary systemic vasculitis. International Journal of Advances in Rheumatology, 7(1), pp. 12-20.

2008

Miller, A., Basu, N. and Luqmani, R. (2008) Assessment of systemic vasculitis. Autoimmunity Reviews, 8(2), pp. 170-175. (doi: 10.1016/j.autrev.2008.07.001) (PMID:18672099)

Basu, N. (2008) Development of biological therapies for inflammatory arthritis. In: Reid, D. M. and Miller, C. G. (eds.) Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Springer, pp. 37-49. ISBN 9781852338749

2007

Basu, N. and Reid, D. M. (2007) Bisphosphonate-associated osteonecrosis of the jaw. Menopause International, 13(2), pp. 56-59. (doi: 10.1258/175404507780796361) (PMID:17540134)

2005

Basu, N. and Reid, D.M. (2005) Paget’s disease of the bone. Prescriber, 16(21), pp. 37-41.

2002

Whittle, I.R., Basu, N. , Grant, R., Walker, M. and Gregor, A. (2002) Management of patients aged ≫60 years with malignant glioma: good clinical status and radiotherapy determine outcome. British Journal of Neurosurgery, 16(4), pp. 343-347. (doi: 10.1080/02688690021000007650) (PMID:12389886)

This list was generated on Tue Apr 23 01:11:48 2024 BST.

Jump to: Articles | Book Sections | Conference or Workshop Item